Distance Education Versus Usual Care Qualification in Asthma Care (RESPIRANET)
|ClinicalTrials.gov Identifier: NCT01595971|
Recruitment Status : Completed
First Posted : May 10, 2012
Last Update Posted : May 15, 2017
|Condition or disease||Intervention/treatment|
|Asthma||Behavioral: Continuing education Other: usual care|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||467 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Primary Purpose:||Health Services Research|
|Official Title:||Distance Education Versus Usual Care in the Qualification of Asthma Care: A Cluster Randomized Clinical Trial - RESPIRANET|
|Actual Study Start Date :||August 12, 2010|
|Primary Completion Date :||December 16, 2011|
|Study Completion Date :||December 16, 2011|
Experimental: continuing education
RESPIRANET is a multifaceted intervention directed at professionals of the Family Health Teams in the inner cities.Includes telemedicine, reminders, video conferences, educational materials for patients and consultants.
Behavioral: Continuing education
Includes telemedicine, reminders, video conferences, educational materials for patients and consultants.
Other Name: RESPIRANET
Placebo Comparator: Usual Care
Other: usual care
Received the usual care provided
- Symptom burden, measured as the number of self-reported asthma symptom days (ASD). ASD is based on 2 week recall. [ Time Frame: six months ]The definition of a symptom day includes presence of any of the four types of asthma symptoms: wheeze, cough, night time awakening ou shortness of breath. The results will be collected through the application of standardized questionnaires.
- Asthma control [ Time Frame: 6 months ]Control of asthma will be evaluated by the excessive use of relief medication in the last month.
- Health care utilization [ Time Frame: 6 meses ]Proportion of unscheduled medical visits during the follow-up
- Proportion of patients in use inhaled corticosteroids [ Time Frame: 6 meses ]Use of inhaled corticosteroids assessed by the proportion of patients who require medication to prevent asthma symptoms that are in use of inhaled corticosteroids.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01595971
|Hospital de clínicas de Porto Alegre|
|Porto Alegre, Rio grande do sul, Brazil|
|Study Chair:||Erno Harzheim, PHD||Federal University of Rio Grande do Sul|